Pressemitteilungen

Alle
down arrow
  • Alle
  • Regulatorisch
  • Nicht-regulatorisch
  • 2022-12-01 Non-regulatory

    NeoDynamics appoints Matthew Colpoys, to lead US operations

    Weiterlesen
  • 2022-11-17 Regulatory

    NeoDynamics Interim Report January-September 2022

    Weiterlesen
  • 2022-11-16 Non-regulatory

    NeoDynamics gears up for US launch by partnering with Diligent

    Weiterlesen
  • 2022-11-08 Non-regulatory

    NeoDynamics hires National Sales Director for the launch of its NeoNavia® Biopsy System

    Weiterlesen
  • 2022-10-25 Non-regulatory

    Changing Breast Cancer Treatment with the NeoNavia[®] Biopsy System

    Weiterlesen
  • 2022-10-20 Non-regulatory

    NeoDynamics to present at Redeye’s Medtech Seminar on October 26

    Weiterlesen
  • 2022-09-21 Non-regulatory

    NeoDynamics appoints Decomplix as Swiss representative

    Weiterlesen
  • 2022-09-08 Regulatory

    NeoDynamics received FDA clearance for pulse biopsy system NeoNavia®

    Weiterlesen
  • 2022-08-18 Regulatory

    NeoDynamics Interim Report Jan-June 2022

    Weiterlesen
  • 2022-08-16 Non-regulatory

    Meet NeoDynamics Matt E. Colpoys

    Weiterlesen
  • 2022-07-07 Non-regulatory

    NeoDynamics receives ethical approval for German device registry

    Weiterlesen
  • 2022-06-17 Non-regulatory

    Gryningskust Holding AB increases ownership in NeoDynamics

    Weiterlesen
  • 2022-06-09 Non-regulatory

    Update on the FDA approval process for NeoNavia®

    Weiterlesen